Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: Involvement of the NPY Y1 receptor subtype

European Journal of Neuroscience

Volumn 24, Issue 2, 2006, Pages 499-508

  Díaz Cabiale, Zaida ^a   Parrado, Concepción ^b   Rivera, Alicia ^b   De La Calle, Adelaida ^b   Agnati, Luigi ^c   Fuxe, Kjell ^d   Narváez, José A ^a  

^a Camp Universitario Teatinos   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoradiography; NTS; Rat

Indexed keywords

GALANIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; HEART RATE; IMMUNOREACTIVITY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TACHYCARDIA;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BINDING, COMPETITIVE; BLOOD PRESSURE; BRADYKININ; CARDIOVASCULAR PHYSIOLOGY; DRUG SYNERGISM; GALANIN; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; NEURAL PATHWAYS; NEUROPEPTIDE Y; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-FOS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GALANIN; RECEPTORS, NEUROPEPTIDE Y; SOLITARY NUCLEUS; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 33746215799     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04937.x     Document Type: Article

References (42)

1. AbdAlla, S., Abdel-Baset, A., Lother, H., el Massiery, A. & Quitterer, U. (2005) Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J. Mol. Neurosci., 26, 185-192.
2. Agnati, L.F., Franzen, O., Ferre, S., Leo, G., Franco, R. & Fuxe, K. (2003) Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J. Neural Transm. Suppl., 65, 1-28.
3. Agnati, L.F., Tarakanov, A.O., Ferre, S., Fuxe, K. & Guidolin, D. (2005) Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development. J. Mol. Neurosci., 26, 193-208.
4. Aguirre, J.A., Fuxe, K., Agnati, L.F. & Von Euler, G. (1990) Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake males rats. Neurosci. Lett., 118, 5-8.
5. Antoniou, K., Kehr, J., Smitt, K. & Ögren, S.O. (1997) Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats. Eur. J. Pharmacol., 121, 1180-1186.
6. Barraco, R.A., Ergene, E., Dunbar, J.C. & El-Ridi, M.R. (1990) Cardiorespiratory response patterns elicited by microinjections of neuropeptide Y in the nucleus tractus solitarius. Brain Res. Bull., 24, 465-485.
7. Bartfai, T., Fisone, G. & Langel, Ü. (1992) Galanin and galanin antagonists-molecular and biochemical perspectives. Trends Pharmacol. Sci., 13, 312-317.
8. Branchek, T., Smith, K.E. & Walter, M.W. (1998) Molecular biology and pharmacology of galanin receptors. Ann. NY Acad. Sci., 863, 94-107.
9. Crawley, J.N., Mufson, E.J., Hohmann, J.G., Teklemichael, D., Steiner, R.A., Holmberg, K., Xu, Z.Q., Blakeman, K.H., Xu, X.J., Wiesenfeld-Hallin, Z., Bartfai, T. & Hokfelt, T. (2002) Galanin overexpressing transgenic mice. Neuropeptides, 361, 45-56.
10. 2- adrenoreceptor interactions in the nucleus tractus solitarius. J. Neural. Transm. (special issue), in press?).
11. Díaz-Cabiale, Z., Cordón, M.P., Coveñas, R., Rivera, A., Yanaihara, N., Fuxe. K., González-Barón, S. & Narváez, J.A. (2002) Propranolol blocks the tachycardia induced by Galanin (1-15) but not by Galanin (1-29). Regul. Pept., 107, 29-36.
12. Díaz-Cabiale, Z., Fuxe, K., Coveñas, R., Gonzalez-Baron, S. & Narvaez, J.A. (2003) Angiotensin II modulates the cardiovascular responses to microinjection of NPY Y1 and NPY Y2 receptor agonists into the nucleus tractus solitarii of the rat. Brain Res., 983, 193-200.
13. Díaz-Cabiale, Z., Narváez, J.A., García-Coronel, M. & Fuxe, K. (2001) Galanin/alpha2-adrenoceptor interactions in telencephalic and diencephalic regions of the rat. Neuroreport, 12, 151-155.
14. Díaz-Cabiale, Z., Narváez, J.A., Marcos, P., Cordón, M.P., Covenas, R., Fuxe, K. & Gonzalez-Baron, S. (1998) Galanin and NH2-terminal galanin fragments in central cardiovascular regulation. Ann. NY Acad. Sci., 863, 421-424.
15. Díaz-Cabiale, Z., Narváez, J.A., Yanaihara, N., González-Barón, S. & Fuxe, K. (2000) Galanin/alpha2-receptor interactions in central cardiovascular control. Neuropharmacology, 39, 1377-1385.
16. Díaz-Cabiale, Z., Parrado, C., Vela, C., Coveñas, R., Yanaihara, N., Fuxe, K., González-Barón, S. & Narváez, J.A. (2005b) Intracisternal Galanin/Angiotensin II interactions in central cardiovascular control. Regul. Pept., 127, 133-140.
17. Díaz-Cabiale, Z., Parrado, C., Vela, C., Razani, H., Covenas, R., Fuxe, K. & Narváez, J.A. (2005a) Role of galanin and galanin (1-15) on central cardiovascular control. Neuropeptides, 39, 185-190.
18. Dinger, M.C., Bader, J.E., Kobor, A.D., Kretzschmar, A.K. & Beck-Sickinger, A.G. (2003) Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem., 278, 10562-10567.
19. Dumont, Y., Fournier, A., St-Pierre, S. & Quirion, R. (1993) Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J. Neurosci., 13, 73-86.
20. Everitt, B.J., Hokfelt, T., Terenius, L., Tatemoto, K., Mutt, V. & Goldstein, M. (1984) Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience, 11, 443-462.
21. Fior, D.R., Hedlund, P.B. & Fuxe, K. (1993) Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain Neurosci. Lett., 26, 58-62.
22. 2-adrenoceptor interaction in the nucleus tractus solitarii. Eur. J. Pharmacol., 262, 271-282.
23. Fuxe, K., Agnati, L.F., Härfstrand, A., Janson, A.M., Neumeyer, A., Andersson, K., Ruggeri, M., Zoli, M. & Goldstein, M. (1986) Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor-receptor interactions in cotransmission. Prog. Brain Res., 68, 303-320.
24. Fuxe, K., Aguirre, J.A., Agnati, L.F., Von Euler, G., Hedlund, P., Coveñas, R., Zoli, M., Bjelke, B. & Eneroth, P. (1990) Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons. Ann. NY Acad. Sci., 611, 111-132.
25. 2-adrenergic and neuropeptide Y mechanisms. J. Cardiovasc. Pharmacol., 10, 199-204.
26. Hedlund, P.B., Aguirre, J.A., Narváez, J.A. & Fuxe, K. (1991) Centrally coinjected galanin and a 5-HT1A agonist act synergistically to produce vasodepressor responses in the rat. Eur J. Pharmacol., 204, 87-95.
27. Marcos, P., Díaz-Cabiale, Z., Cordón, M.P., Coveñas, R., Yanaihara, N., Fuxe, K., González-Barón, S. & Narváez, J.A. (2001) Central galanin and N-terminal galanin fragment induce c-Fos immunoreactivity in the medulla oblongata of the anesthetized rat. Peptides, 22, 1501-1509.
28. Melander, T., Hökfelt, T., Rökaeus, M., Cuello, A.C., Oertel, W.H., Verhofstad, A. & Goldstein, M. (1986) Coexistence of galanin-like immunoreactivity with cathecholamines, 5-hydroxy-tryptamine, Gaba and neuropeptides in the rat. J. Neurosci., 6, 3640-3654.
29. Narváez, J.A., Aguirre, J.A. & Fuxe, K. (1993) Subpicomolar amounts of NPY (13-36) injected into the nucleus tractus solitarius of the rat counteract the cardiovascular responses to 1-glutamate. Neurosci. Lett., 151, 182-186.
30. 1A receptor agonist 8-OH-DPAT. Eur. J. Pharmacol., 257, 257-265.
31. O'Donnell, D., Ahmad, S., Wahlestedt, C. & Walker, P. (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comp. Neurol., 409 (3), 469-481.
32. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academis Press Inc., San Diego, California, USA.
33. 125I-galanin binding sites in the rat central nervous system. Peptides, 7, 1029-1042.
34. Tatemoto, K., Rökaeus, A., Jörnvall, H., McDonald, T.J. & Mutt, V. (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett., 164, 124-128.
35. Waters, S.M. & Krause, J.E. (2000) Distribution of galanin-1 -2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience, 95, 265-271.
36. Wiesenfeld-Hallin, Z., Xu, X.J., Langel, U., Bedecs, K., Hökfelt, T. & Bartfai, T. (1992) Galanin-mediated control of pain: enhanced role after nerve injury. Proc. Natl Acad. Sci. USA, 89, 3334-3337.
37. Wirz, S.A., Davis, C.N., Lu, X., Zal, T. & Bartfai, T. (2005) Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides, 39, 535-546.
38. Wynick, D., Thomson, S.W. & McMahon, S.B. (2001) The role of galanin as a multi-functional neuropeptide in the nervous system. Curr. Opin. Pharmacol., 1, 73-77.
39. Yang, S.N., Bjelke, B., Narváez, J.A., Cintra, A., Agnati, L.F. & Fuxe, K. (1995) Counteraction of NYP-induced c-Fos expression in the nucleus tractus solitarii by alpha 2 receptor agonists. Neuroreport, 6, 384-388.
40. Yang, S.N., Fior, D.R., Hedlund, P.B., Agnati, L.F. & Fuxe, K. (1994b) Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii. Eur. J. Pharmacol., 271, 201-212.
41. Yang, S.N., Fior, D.R., Hedlund, P.B., Narváez, J.A., Agnati, L.F. & Fuxe, K. (1994a) Coinjections of NPY (1-36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline. Neurosci. Lett., 171, 27-31.
42. Yang, S.N., Narváez, J.A., Bjelke, B., Agnati, L.F. & Fuxe, K. (1993) Microinjections of subpicomolar amounts of NPY (13-36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY (1-36) and of a NPY Y1 receptor agonist. Brain Res., 621, 126-132.